PDCD1 and breast cancer: By regularly monitoring tumor volume growth and analyzing the tumor growth curves and tumor weight,we found that gavage with P. distasonis combined with α-PD-1 mAb treatment could significantly inhibit tumor growth and reduce tumor weight compared to the BC + α-PD-1 mAb treatment group (p<0.05, p<0.001) (Fig. 5B).